Regular salmeterol vs salbutamol
All‐cause non‐fatal serious adverse events ‐ adults and adolescents · patients with chronic asthma
Regular salmeterol showed no clear difference in all‐cause non‐fatal serious adverse events ‐ adults and adolescents compared with regular salbutamol (moderate certainty).
1 finding from 1 review
- Regular treatment with salmeterol for chronic asthma: serious adverse events 2008 · Cochrane Headline outcomes onlyOR 0.96 [0.85, 1.1]5 studies · 27002 participantsModerate